U.S. government ban on sale of some Apple Watch models temporarily halted
- Apple wins temporary reprieve from ban on sale of some Apple Watch models
- U.S. International Trade Commission found Apple infringed two patents
- U.S. Trade Representative decides not to reverse ITC determination
- Federal Circuit court issues interim stay on ban
- Government granted extension to reply to Apple’s filing
- Apple stops selling Series 9 and Ultra 2 watches
- Apple disagrees with ITC decision and is working to resume sales
- Apple Watch SE models still available for sale
- Apple pursuing legal and technical options to resume sales
- Apple and Masimo have not commented on court’s ruling
- Apple’s stock down 0.3%, Masimo’s stock down 2.9%
Apple has won a temporary reprieve from a U.S. government ban on the sale of some Apple Watch models. The ban was imposed after the U.S. International Trade Commission found that Apple had infringed two patents related to sensors that measure blood oxygen levels. However, the U.S. Trade Representative decided not to reverse the ITC determination, prompting Apple to appeal the decision to the Federal Circuit court. The court has issued an interim stay on the ban while it considers a motion for a further stay pending appeal. Apple has stopped selling the affected watch models and is working to resume sales as soon as possible. In the meantime, Apple Watch SE models remain available for sale. Apple is pursuing legal and technical options to address the ban and has submitted a proposed redesign for the affected watch models for U.S. Customs approval. Neither Apple nor the patent holder, Masimo, have commented on the court’s ruling. Apple’s stock was down 0.3% following the news, while Masimo’s stock was down 2.9%.
Public Companies: Apple (AAPL), Masimo (MASI)
Private Companies: undefined
Key People: Katherine Tai (U.S. Trade Representative)
Factuality Level: 7
Justification: The article provides information about Apple winning a temporary reprieve from a U.S. government ban on the sale of some Apple Watch models. It mentions the patents held by Masimo and Ceracor Laboratories that Apple was found to have infringed. It also mentions the appeal filed by Apple and the court’s interim stay on the ban. The article includes statements from Apple and mentions that the ITC order doesn’t affect watches already in use. The article provides stock trading information for Apple and Masimo. Overall, the article provides factual information about the situation.
Noise Level: 3
Justification: The article provides a concise and factual report on Apple winning a temporary reprieve from a U.S. government ban on the sale of some Apple Watch models. It includes information on the patents involved, the review process, and Apple’s response. The article stays on topic and does not dive into unrelated territories. However, it lacks in-depth analysis, scientific rigor, and actionable insights.
Financial Relevance: Yes
Financial Markets Impacted: Apple and Masimo
Presence of Extreme Event: No
Nature of Extreme Event: No
Impact Rating of the Extreme Event: No
Justification: The article pertains to a legal dispute between Apple and Masimo regarding patents for sensors that measure blood oxygen levels in Apple Watch models. The U.S. International Trade Commission found that Apple infringed on two patents held by Masimo and Ceracor Laboratories. The U.S. Trade Representative decided not to reverse the ITC determination, leading Apple to appeal the decision to the Federal Circuit court. The court issued an interim stay on the ban, allowing Apple to continue selling the affected Apple Watch models while the court considers a motion for a further stay pending appeal. The impact of this event on financial markets is limited to the stock prices of Apple and Masimo, with Apple experiencing a slight decrease in stock price and Masimo seeing a larger decrease.
www.marketwatch.com 
